These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 3153487
1. Perspectives on infection with HIV-1 among intravenous drug users. Vlahov D, Polk BF. Psychopharmacol Bull; 1988; 24(3):325-9. PubMed ID: 3153487 [No Abstract] [Full Text] [Related]
2. Strategies for enhancing existing studies of the natural history of HIV-1 infection among drug users. Chitwood DD, Comerford M, Trapido EJ. NIDA Res Monogr; 1991; 109():9-28. PubMed ID: 1753993 [No Abstract] [Full Text] [Related]
5. Predictors of HIV seropositivity in Newark and Jersey City i.v. drug users not currently enrolled in treatment. Iguchi MY, Rosen M, Musikoff H, Kushner H, French J, Baxter R, Lidz V, Platt JJ, Grant C. NIDA Res Monogr; 1990; 105():473-4. PubMed ID: 1876086 [No Abstract] [Full Text] [Related]
6. Community-based AIDS prevention interventions: special issues of women intravenous drug users. Mondanaro J. NIDA Res Monogr; 1990; 93():68-82. PubMed ID: 2300149 [No Abstract] [Full Text] [Related]
7. The change from intravenous to crack cocaine and its impact on reducing HIV incidence in Brazilian prisons. Burattini MN, Strazza L, Paoliello AA, de Carvalho HB, de Azevedo RS, Coutinho FA, Massad E. Int J STD AIDS; 2005 Dec; 16(12):836-7. PubMed ID: 16336774 [No Abstract] [Full Text] [Related]
9. Intravenous drug abusers with antisocial personality disorder: high rate of HIV-1 infection. Brooner RK, Bigelow GE, Greenfield L, Strain EC, Schmidt CW. NIDA Res Monogr; 1990 Dec; 105():488-9. PubMed ID: 1876094 [No Abstract] [Full Text] [Related]
10. Interest in HIV vaccines among Italian injection drug users. The Network Interregionale SERT. Serpelloni G, Vlahov D, Mazzi M, Rezza G. J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct 01; 10(2):206-7. PubMed ID: 7552488 [No Abstract] [Full Text] [Related]
13. Viability of HIV-1 in syringes: implications for interventions among injection drug users. Heimer R, Abdala N. AIDS Read; 2000 Jul 01; 10(7):410-7. PubMed ID: 10932845 [Abstract] [Full Text] [Related]
14. [Innovative factors in a syringe exchange program for drug users in Barcelona]. Royo J, Carme Viladrich M, Guirado MV, Bayés R. Med Clin (Barc); 1994 Mar 19; 102(10):397-8. PubMed ID: 8182991 [No Abstract] [Full Text] [Related]
16. Lessons from the history of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among Spanish drug injectors. De La Fuente L, Bravo MJ, Barrio G, Parras F, Suárez M, Rodés A, Noguer I. Clin Infect Dis; 2003 Dec 15; 37 Suppl 5():S410-5. PubMed ID: 14648456 [Abstract] [Full Text] [Related]
18. Vitamin D receptor gene haplotypes and susceptibility to HIV-1 infection in injection drug users. de la Torre MS, Torres C, Nieto G, Vergara S, Carrero AJ, Macías J, Pineda JA, Caruz A, Fibla J. J Infect Dis; 2008 Feb 01; 197(3):405-10. PubMed ID: 18205531 [Abstract] [Full Text] [Related]
20. NIDA, HRSA join forces in studies of AIDS risk behavior by i.v. drug users. Delaney P. Public Health Rep; 1990 Feb 01; 105(3):323. PubMed ID: 2113694 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]